{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T23:14:46Z","timestamp":1776467686616,"version":"3.51.2"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":721,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jtct.2021.03.013","type":"journal-article","created":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T01:56:01Z","timestamp":1616118961000},"page":"492.e1-492.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Nonmyeloablative Conditioning Regimen Including Low-Dose Total Marrow\/Lymphoid Irradiation Before Haploidentical Transplantation with Post-Transplantation Cyclophosphamide in Patients with Advanced Lymphoproliferative Diseases"],"prefix":"10.1016","volume":"27","author":[{"given":"Barbara","family":"Sarina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Mancosu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierina","family":"Navarria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Bramanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacopo","family":"Mariotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"De Philippis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Clerici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ciro","family":"Franzese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Mannina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viviana","family":"Valli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmelo","family":"Carlo-Stella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Scorsetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armando","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Castagna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2021.03.013_bib0001","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/bmt.2017.34","article-title":"Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report","volume":"52","author":"Passweg","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.03.013_bib0002","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1038\/bmt.2017.59","article-title":"A review of hematopoietic cell transplantation in China: data and trends during 2008-2016","volume":"52","author":"Xu","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.03.013_bib0003","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1182\/blood-2012-08-453399","article-title":"Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies","volume":"121","author":"Di Bartolomeo","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.03.013_bib0004","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","article-title":"HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide","volume":"14","author":"Luznik","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.03.013_bib0005","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/bbmt.2002.v8.pm11939602","article-title":"Posttransplantation cyclophosphamide facilitates engraftment of major histocompatibility complex-identical allogeneic marrow in mice conditioned with low-dose total body irradiation","volume":"8","author":"Luznik","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.03.013_bib0006","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.bbmt.2012.07.003","article-title":"Improved early outcomes using a T cell-replete graft compared with T cell-depleted haploidentical hematopoietic stem cell transplantation","volume":"18","author":"Ciurea","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.03.013_bib0007","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/j.bbmt.2012.06.019","volume":"18","author":"Solomon","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.03.013_bib0008","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bbmt.2012.08.014","article-title":"Unmanipulated haploidentical bone marrow transplantation and posttransplantation cyclophosphamide for hematologic malignancies after myeloablative conditioning","volume":"19","author":"Raiola","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.03.013_bib0009","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1182\/bloodadvances.2019000627","article-title":"Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy","volume":"3","author":"Solomon","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2021.03.013_bib0010","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1118\/1.2044428","article-title":"Feasibility study of helical tomotherapy for total body or total marrow irradiation","volume":"32","author":"Hui","year":"2005","journal-title":"Med Phys"},{"key":"10.1016\/j.jtct.2021.03.013_bib0011","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/153303460900800104","article-title":"Multimodality image guided total marrow irradiation and verification of the dose delivered to the lung, PTV, and thoracic bone in a patient: a case study","volume":"8","author":"Hui","year":"2009","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.jtct.2021.03.013_bib0012","doi-asserted-by":"crossref","first-page":"5609","DOI":"10.1118\/1.2990779","article-title":"Feasibility study for linac-based intensity modulated total marrow irradiation","volume":"35","author":"Wilkie","year":"2008","journal-title":"Med Phys"},{"key":"10.1016\/j.jtct.2021.03.013_bib0013","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.ijrobp.2010.11.035","article-title":"Total marrow irradiation with RapidArc volumetric arc therapy","volume":"81","author":"Aydogan","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jtct.2021.03.013_bib0014","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.ijrobp.2010.11.028","article-title":"Preclinical assessment of volumetric modulated arc therapy for total marrow irradiation","volume":"80","author":"Fogliata","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jtct.2021.03.013_bib0015","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.radonc.2011.06.005","article-title":"Dosimetric study of volumetric modulated arc therapy fields for total marrow irradiation","volume":"102","author":"Han","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.jtct.2021.03.013_bib0016","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.phro.2019.08.001","article-title":"Total marrow irradiation for hematopoietic malignancies using volumetric modulated arc therapy: a review of treatment planning studies","volume":"11","author":"Mancosu","year":"2019","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.jtct.2021.03.013_bib0017","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.03.013_bib0018","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1120\/jacmp.v13i1.3653","article-title":"Anatomy driven optimization strategy for total marrow irradiation with a volumetric modulated arc therapy technique","volume":"13","author":"Mancosu","year":"2012","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.jtct.2021.03.013_bib0019","doi-asserted-by":"crossref","DOI":"10.1118\/1.4823767","article-title":"Interplay effects between dose distribution quality and positioning accuracy in total marrow irradiation with volumetric modulated arc therapy","volume":"40","author":"Mancosu","year":"2013","journal-title":"Med Phys"},{"key":"10.1016\/j.jtct.2021.03.013_bib0020","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13014-015-0391-y","article-title":"In-vivo dosimetry with Gafchromic films for multi-isocentric VMAT irradiation of total marrow lymph-nodes: a feasibility study","volume":"10","author":"Mancosu","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.jtct.2021.03.013_bib0021","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ejmp.2015.05.012","article-title":"Plan robustness in field junction region from arcs with different patient orientation in total marrow irradiation with VMAT","volume":"31","author":"Mancosu","year":"2015","journal-title":"Phys Med"},{"key":"10.1016\/j.jtct.2021.03.013_bib0022","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.03.013_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.03.013_bib0024","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.bbmt.2014.02.001","article-title":"Bone marrow compared with peripheral blood stem cells for haploidentical transplantation with a nonmyeloablative conditioning regimen and posttransplantation cyclophosphamide","volume":"20","author":"Castagna","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.03.013_bib0025","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3324\/haematol.2015.132860","article-title":"Nonmyeloablative allogeneic hematopoietic cell transplantation","volume":"101","author":"Storb","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2021.03.013_bib0026","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1182\/blood.2018874115","article-title":"Total body irradiation dose and risk of subsequent neoplasms following allogeneic hematopoietic cell transplantation","volume":"133","author":"Baker","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.03.013_bib0027","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/B978-0-323-56802-9.00007-9","article-title":"T-cell replete haploidentical transplantation","author":"Castagna","year":"2019","journal-title":"Hematopoietic Cell Transplantation for Malignant Conditions"},{"key":"10.1016\/j.jtct.2021.03.013_bib0028","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.bbmt.2017.01.067","article-title":"Phase I trial of total marrow and lymphoid irradiation transplant conditioning in patients with relapsed\/refractory acute leukemia","volume":"23","author":"Stein","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.03.013_bib0029","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1182\/blood-2010-06-288357","article-title":"Phase 1\/2 trial of total marrow and lymph node irradiation to augment reduced-intensity transplantation for advanced hematologic malignancies","volume":"117","author":"Rosenthal","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.03.013_bib0030","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.bbmt.2017.09.019","article-title":"Total marrow lymphoid irradiation\/fludarabine\/melphalan conditioning for allogeneic hematopoietic cell transplantation","volume":"24","author":"Jensen","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.03.013_bib0031","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1182\/bloodadvances.2017014829","article-title":"Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamide","volume":"2","author":"McCurdy","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2021.03.013_bib0032","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1182\/blood-2015-09-671834","article-title":"Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors","volume":"127","author":"Kanate","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.03.013_bib0033","doi-asserted-by":"crossref","first-page":"e477","DOI":"10.1016\/S1470-2045(20)30342-9","article-title":"Total marrow and total lymphoid irradiation in bone marrow transplantation for acute leukaemia","volume":"21","author":"Wong","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtct.2021.03.013_bib0034","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1200\/JCO.20.02529","article-title":"Total body irradiation or chemotherapy conditioning in childhood ALL: a multinational, randomized, noninferiority phase III study","volume":"39","author":"Peters","year":"2021","journal-title":"J Clin Oncol"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636721007673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636721007673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T05:04:25Z","timestamp":1725339865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636721007673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S2666636721007673"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2021.03.013","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonmyeloablative Conditioning Regimen Including Low-Dose Total Marrow\/Lymphoid Irradiation Before Haploidentical Transplantation with Post-Transplantation Cyclophosphamide in Patients with Advanced Lymphoproliferative Diseases","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2021.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}